IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2017 Holdings

Filed 2017-11-14 | 9 holdings | $121.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$120.2M383,85899.1%
Abbvie Inc.(ABBV)COM00287Y109$888.0K10,0000.7%
Bioverativ IncCOM09075R100$66.5K1,165,0000.1%
Medicines CoCOM584688105$64.9K1,752,0000.1%
Innoviva Inc(INVA)COM45781M101$50.8K3,600,7050.0%
Achillion Pharmaceuticals Inc(ACHNEUR)COM00448Q201$9.6K2,136,8000.0%
Novelion Therapeutics IncCOM NEW67001K202$7.2K1,025,0000.0%
Apricus Biosciences IncCOM NEW03832V307$2.5K1,447,9060.0%
Advaxis IncCOM NEW007624208$1.4K339,1800.0%